This article is more than 5 years old. Information may no longer be current.
Centerflex IOL associated with low capsulotomy rate at 3 years postop
Click Here to Manage Email Alerts
SAN DIEGO — The Centerflex foldable hydrophilic acrylic IOL was associated with a 5.2% rate of symptomatic posterior capsular opacification requiring Nd:YAG capsulotomy after 3 years in vivo, a retrospective study found.
Rebecca L. Ford, MD, and colleagues at Whipps Cross Hospital, London, and Harold Wood Hospital in Romford, England, reviewed the rate of Nd:YAG capsulotomies performed from 2000 to 2003 in patients implanted with the Centerflex single-piece IOL (Rayner). Dr. Ford presented their results here at the American Society of Cataract and Refractive Surgery meeting.
Four senior surgeons at the two hospitals performed 3,325 routine cataract surgeries with Centerflex implantation. Of these, 172 required laser capsulotomies (5.2%) within the 3-year period, Dr. Ford said.
"It seems that the peak time was within 16 months of surgery," she said.
The lens, which features a squared optic and haptic edge design, has been used in England for the last 10 years. The U.S. Food and Drug Administration is currently reviewing the application for U.S. marketing of the lens, she said.